Having established that activation of KCa3.1 channels caused marked uptake and accumulation of a known DNA-binding cytotoxin, we hypothesized that KCa3.1 activators might facilitate selective sensitivity of cancer cells to small DNA-binding drugs. Here, KCNN4 is linked to cancer.